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Abstract
Background: Prior studies of clinical prognostication in idiopathic pulmonary fibrosis (IPF) using computed
tomography (CT) have often used subjective analyses or have evaluated quantitative measures in isolation. This
study examined associations between both densitometric and local histogram based quantitative CT measurements
with pulmonary function test (PFT) parameters and mortality. In addition, this study sought to compare risk
prediction scores that incorporate quantitative CT measures with previously described systems.
Methods: Forty six patients with biopsy proven IPF were identified from a registry of patients with interstitial lung
disease at Brigham and Women’s Hospital in Boston, MA. CT scans for each subject were visually scored using a
previously published method. After a semi-automated method was used to segment the lungs from the
surrounding tissue, densitometric measurements including the percent high attenuating area, mean lung density,
skewness and kurtosis were made for the entirety of each patient’s lungs. A separate, automated tool was used to
detect and quantify the percent of lung occupied by interstitial lung features. These analyses were used to create
clinical and quantitative CT based risk prediction scores, and the performance of these was compared to the
performance of clinical and visual analysis based methods.
Results: All of the densitometric measures were correlated with forced vital capacity and diffusing capacity, as were
the total amount of interstitial change and the percentage of interstitial change that was honeycombing measured
using the local histogram method. Higher percent high attenuating area, higher mean lung density, lower
skewness, lower kurtosis and a higher percentage of honeycombing were associated with worse transplant free
survival. The quantitative CT based risk prediction scores performed similarly to the clinical and visual analysis based
methods.
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Conclusions: Both densitometric and feature based quantitative CT measures correlate with pulmonary function
test measures and are associated with transplant free survival. These objective measures may be useful for
identifying high risk patients and monitoring disease progression. Further work will be needed to validate these
measures and the quantitative imaging based risk prediction scores in other cohorts.
Keywords: Interstitial lung disease, Idiopathic pulmonary fibrosis, Computed tomography, Quantitative, Imaging,
Mortality
Background
Idiopathic pulmonary fibrosis (IPF) is a progressive and
usually fatal disease. While the median survival is only
2.53.5 years without treatment, the clinical course can
be variable, and the prediction of IPF related outcomes
in an individual can be challenging [1, 2]. IPF severity is
often described using pulmonary function test (PFT) pa-
rameters, or using systems such as the GAP index,
which incorporates gender, age, forced vital capacity
(FVC) and diffusing capacity (DLCO) into a risk predic-
tion model [3]. Because patients with IPF usually have
had a computed tomography (CT) scan, both qualitative
and quantitative CT measurements have also been stud-
ied to determine their associations with PFT measures
and clinical outcomes [4–15]. These studies have often
used volumetric CT data acquired in a research setting,
and there has been limited investigation into what
additional information CT measurements provide above
and beyond risk prediction models such as the GAP
index [16].
In this study, using clinically acquired non-volumetric
data, we aimed to validate previously described associa-
tions of densitometric quantitative CT measurements
with PFT parameters and mortality in IPF. [6, 17] In
addition, we have developed a fully automated method
that uses the local histogram pattern of lung density
combined with the distance from the pleural surface to
quantify the volume of radiographic tissue subtypes that
make up normal, emphysematous, and interstitial tissues
[18, 19]. We hypothesized that the total percentage of
interstitial disease and the percentage of disease that was
the honeycombing subtype would be associated with
FVC, DLCO and mortality in IPF. In addition, we aimed
to compare the prognostic value of a previously de-
scribed clinical and visual analysis based risk prediction
system with those based on clinical and objective mea-
sures [16]. Specifically, because a visually calculated fi-
brosis score had been previously described to be able to
substitute for diffusing capacity in the GAP score, we hy-
pothesized that the objectively measured interstitial
changes, measured either directly using a local histo-
gram based detection system, or indirectly in the form
of high attenuation areas, could be used in a similar
manner [4, 16, 20]. Finally, because honeycombing has
been shown to be related to poor outcomes in IPF,
we hypothesized that the percentage of interstitial dis-
ease that was honeycombing could be used in the
same way [4].
Methods
Study design and data acquisition
The David E. Herlihy Data Registry and DNA Repository
is an institutional review board approved registry of pa-
tients with ILD at Brigham and Women’s Hospital in
Boston, MA (Partners Institutional Review Board Protocol
Number 2012-P-000840/1). All patients over the age of 18
receiving care for interstitial lung disease (ILD) at Brigham
and Women’s Hospital are eligible to enroll. At the time
of enrollment patients have the option to opt in or out of
the 5 portions of the study including a research question-
naire, medical history review, serum and plasma banking,
genetic testing, and future contact for other studies. All
patients in the registry provided informed consent and
only those patients who consented to medical history re-
view, which specifically includes the analysis of imaging
data, were considered for this study. Only those patients
who had a prior lung biopsy that showed usual interstitial
pneumonia (UIP), and who had CT imaging and spirom-
etry within 48 h of each other were included. Patients
whose longitudinal follow up data were not available, in-
cluding lung transplant status and mortality, were
excluded. All testing was performed only as clinically
indicated.
Objective CT analyses
The CT images used for this study were those typically
termed “high resolution”: non-volumetric 1 mm slices
with 10 mm spacing with a sharp kernel image recon-
struction obtained without the administration of intra-
venous contrast. Using a previously described automated
technique, the lung was segmented from the surround-
ing tissue [21]. The axial images were then visually
inspected and manually edited as needed to correct in-
accurate segmentations.
For the densitometric evaluation, the histogram of dis-
tribution of the density of each voxel within the lung
was plotted as shown in Fig. 1, and the skewness, kur-
tosis, and the mean of that distribution (mean lung
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density, MLD) were measured. In addition, the per-
centage of the total volume of tissue that had a dens-
ity between -250 Hounsfield units (HU) and -600 HU
was recorded as the percent high attenuation area
(HAA%) [22].
Full details regarding the local histogram based object-
ive quantification of the volume of radiographic feature
subtypes are available in the (Additional file 1). Briefly,
we used both the properties of the local tissue and the
distance from the pleural surface to determine a
radiographic feature subtype for every portion of the
lung [18, 19, 23]. First, in order to train the subtype
identification tool, a single expert placed a total of 3357
fiducials, in 30 randomly selected subjects, on the
following radiographic subtypes: normal, interstitial
(reticular, centrilobular nodule, linear scar, nodular,
subpleural line, ground glass and honeycombing), and
emphysematous (centrilobular and panlobular) as shown
in Fig. 2.1 This was done to build a library of points to
be used as tissue classifiers. Regions of interest consist-
ing of 30 by 30 in-plane voxels were built around these
training points, and both the local histogram information
and distance from the pleural surface were used to create
a tissue classification vector for each region [18, 19]. After
the training process was completed, the feature vectors of
all of the 30 by 30 in-plane voxel regions within the lungs
Fig. 1 a Representative images from subjects with less severe (Patient 1) and more severe (Patient 2) visual evidence of IPF. b Histograms of
distribution of the number of voxels on the y axis for each tissue density in Hounsfield Units on the x axis. c Summary statistics and selected
pulmonary function test parameters for each subject. Abbreviations: mean lung density (MLD)
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of each of the subjects were classified into tissue subtypes
based on their similarity to the training data as shown in
Fig. 3.
The total percentage of all of the interstitial features
(objective interstitial score, interstitial%) was then deter-
mined by combining the reticular, centrilobular nodule,
linear scar, nodular, subpleural line, ground glass and
honeycombing subtype volumes and dividing by the
total volume of all tissue types (normal, interstitial and
emphysematous). The percentage of interstitial disease
made up of by honeycombing (honeycombing%) was de-
termined by dividing the volume of the honeycombing
subtype by the total volume of all of the interstitial sub-
types. Due to the exploratory nature and small size of
this study, subjects used in the training set were not ex-
cluded from the final analysis.
Visual analysis
The same CT images used for the objective analysis
were reviewed by two experts and the percentage of lung
occupied by fibrotic disease (reticular and honeycomb-
ing) was qualitatively defined as described previously
[16, 24]. Briefly, the two experts determined the percent-
age of lung occupied by reticular and honeycombing
changes in each of six lung zones, three on each side,
with the upper lung zone extending from the apex to
the level of the aortic arch, the middle from the aortic
arch to the inferior pulmonary veins, and the inferior
from the inferior pulmonary veins to the bases. The per-
centages identified by both experts were then averaged
to determine the mean total percentage of lung occupied
by visually defined fibrotic changes, also termed the vis-
ual fibrosis score (fibrosis%) [16, 24].
Fig. 2 a Sample slice for CT scan of a subject. b The same sample slice from a subject CT scan showing placement of fiducials for the training of
the local histogram based objective method. Abbreviations: ground glass (GG), honeycombing (Hon), reticular (Ret), computed tomography (CT)
Fig. 3 a Representative CT images from subjects with less severe IPF (patient 1) and more severe IPF (patient 2). b Overlay of categorization of
lung parenchyma into radiographic subtypes using the local histogram analysis and distance based analysis for each subject. c Legend for
radiographic subtypes
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Statistical analysis
Pearson correlation coefficients were calculated between
the CT measurements (densitometric: MLD, skewness,
kurtosis, HAA%, visual: fibrosis%, and local histogram
based: interstitial%, honeycombing%) and the nearest in
time percent predicted forced vital capacity (FVC%) and
percent predicted diffusing capacity of carbon monoxide
(DLCO%). The Pearson correlation coefficient was also
calculated between the visual fibrosis score (fibrosis%)
and the objective interstitial score (interstitial%).
All of the CT predictors were dichotomized at their
medians and both Kaplan-Meier and univariate Cox re-
gression survival analyses were performed for the out-
come of time to death or transplant (transplant free
survival). Univariate Cox regression survival analyses
were also performed for the outcome of time to death
for the subgroup of subjects who did not undergo trans-
plant. Each predictor was evaluated using the cumulative
sum of Martingale-based residuals and none were found
to violate the proportional hazards assumption [25].
The continuous GAP score was calculated for each
subject as previously published [3]. For the purposes of
the GAP score calculation, subjects who did not have a
DLCO available were assumed to have been unable to
perform the test. The continuous qualitative or visual
GAP-CT score was calculated by using the visual fibrosis
score in place of the DLCO as previously described [16].
Three additional GAP scores were calculated by using
the following quantitative measures in place of the visual
fibrosis score: 1) interstitial% (GAP-QCT), 2) honey-
combing% (GAP-honeycombing), and 3) HAA% (GAP-
HAA). For each of these combination clinical and
imaging scoring methods, their performance with regard
to the prediction of transplant free survival was assessed
using the c-index, which was calculated using the
method described by Pencina et al. [26, 27] The c-index
accommodates censoring, and can be thought of as
similar to the area under the receiver operating curve
for logistic regression, in that it ranges from 0 to 1.0
(variably expressed as 0-100%), and a value of 0.5 indi-
cates no predictive discrimination while a value of 1.0
indicates perfect discrimination [16].
A p value of less than 0.05 was considered to indicate
statistical significance. All analyses were performed using
SAS, version 9.4 (SAS Institute, Cary, NC).
Results
Of the 176 subjects in the registry as of August 15, 2015,
46 (26%) met inclusion criteria. All 46 had longitudinal
data available regarding lung transplant and mortality,
and 36 (78%) had DLCO measurements available for the
same time point as spirometry. The clinical characteristics
Fig. 4 Kaplan Meier survival curves for transplant free survival for the densitometric CT measures. a HAA%, b MLD, c skewness, d kurtosis.
Abbreviations: percentage of high attenuation area (HAA%), mean lung density (MLD)
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of these subjects are shown in Table 1. While the indica-
tions for lung biopsy were not recorded in all cases, visual
review revealed that the majority of subjects had CT find-
ings consistent with UIP.
The visual fibrosis score and the objective interstitial
score were highly correlated (r = 0.77, p < 0.001). All of
the CT measurements, including the densitometric mea-
sures, the quantitative interstitial score, the quantitative
honeycombing measure, and the visual fibrosis score
were strongly correlated with both FVC% and DLCO%
as shown in Table 2. The median follow up duration was
465 days, during which 14 (30%) patients underwent
lung transplant and 12 (26%) died. Higher HAA%,
higher MLD, lower skewness and lower kurtosis were
associated with a shorter transplant free survival as
shown in Fig. 4 a-d and Table 3. Those subjects with
higher fibrosis% and honeycombing% also had a shorter
transplant free survival as shown in Figs. 5a and c and
Table 3. There was trend toward a shorter transplant
free survival for those subjects with higher interstitial%,
but this did not reach statistical significance as shown in
Fig. 5b and Table 3. In the subgroup that did not
undergo transplant, the same features were associated
with increased mortality with the exception of honey-
combing% as shown in Table 3.
The c-indices for the standard GAP score as well
as for the GAP-CT, GAP-QCT, GAP-honeycombing
and GAP-HAA scores are shown in Table 4. With the
exception of the GAP-HAA score all of the calculated
continuous GAP scores had similar c-indices. These
were also similar to the previously published c-indices
for both the standard GAP score and the GAP-CT
score [3, 20].
Discussion
In this study of 46 subjects with biopsy proven IPF we
found that both densitometric and local histogram based
quantitative CT measurements were correlated with
FVC% and DLCO%. Densitometric measures including
higher HAA%, higher MLD, lower skewness and lower
kurtosis, and a higher proportion of local histogram
defined interstitial changes made up of honeycombing
were all associated with shorter transplant free survival.
In addition, in this cohort, GAP scores that utilized
quantitative CT measures of interstitial disease (GAP-
QCT, GAP-honeycombing and GAP-HAA) performed
similarly to the standard GAP score and to the visual
analysis based GAP-CT score with regard to associations
with transplant free survival.












FEV1 - L 2.03 (0.69) 2.02, [1.62, 2.45]
FEV1 % predicted 64.76 (21.05) 64, [49, 82]
FVC - L 2.40 (0.86) 2.36, [1.71, 2.91]
FVC % predicted 60.17 (21.11) 58.5, [44.0, 73.0]
DLCO – mL/min/mmHg 10.40 (3.99) 10.06, [7.75, 12.53]
DLCO % predicted 39.61 (15.66) 37.0, [30.5, 48.5]






Mean Lung Density (HU) -670.14 (86.24) -680.46, [-733.31, -607.03]
Skewness 1.35 (0.55) 1.40, [1.01, 1.79]
Kurtosis 5.06 (2.32) 4.72, [3.18, 6.18]
Percentage of Lung Occupied by
High Attenuation Area, HAA%
17.21 (6.45) 15.41, [12.54, 23.13]




Fibrosis Score, fibrosis% 26.89 (15.80) 22.92, [14.17, 37.50]








68.53 (18.39) 65.75, [57.53, 81.90]
Percentage of Interstitial Disease
Occupied by Honeycombing,
Honeycombing%
26.36 (17.19) 21.65, [12.09, 38.04]
Abbreviations: computed tomography (CT), diffusing capacity of carbon
monoxide (DLCO), forced expiratory volume in 1 s (FEV1), forced vital capacity
(FVC), Hounsfield units (HU), standard deviation (SD)
Table 2 Pearson correlation coefficients for quantitative CT
measures and PFT measures
CT measure FVC % predicted DLCO % predicted
r p r p
Quantitative Densitometric
Mean Lung Attenuation -0.78 <0.001 -0.73 <0.001
Skewness 0.76 <0.001 0.73 <0.001
Kurtosis 0.71 <0.001 0.68 <0.001
Percent High Attenuating Area -0.77 <0.001 -0.69 <0.001
Qualitative




-0.79 <0.001 -0.70 <0.001
Percentage of Interstitial Disease
Occupied by Honeycombing,
Honeycombing%
-0.66 <0.001 -0.66 <0.001
Abbreviations: computed tomography (CT), diffusing capacity of carbon
monoxide (DLCO), forced vital capacity (FVC)
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A multitude of variables have been evaluated as
markers of disease severity in IPF, including clinical
predictors such as symptom based scoring systems, spi-
rometric and other physiologic measures, pathologic
patterns, serum and bronchoalveolar lavage biomarkers,
and both qualitative and quantitative radiographic
measures [4]. Each of these has its advantages and disad-
vantages with regard to accuracy, reproducibility, ease of
use, and applicability at the individual patient level. With
regard to radiographic predictors, both qualitative
Table 3 Unadjusted hazard ratios for death or transplant (A) and for death in those who did not undergo transplant (B) for
measurements dichotomized at their medians
Measurement Hazard ratio for death
or transplant




Mean Lung Density (High vs. Low) 3.27 0.006 5.05 0.015
Skewness (Low vs. High) 2.92 0.012 3.56 0.039
Kurtosis (Low vs. High) 4.49 0.001 4.37 0.013
High Attenuating Area (High vs. Low) 3.17 0.007 7.69 0.009
Qualitative
Fibrosis Score, fibrosis% (High vs. Low) 3.48 0.003 3.96 0.026
Quantitative Feature Based
Quantitative Interstitial Score, interstitial% (High vs. Low) 2.30 0.065 3.51 0.065
Percentage of Interstitial Disease Occupied by Honeycombing, Honeycombing%
(High vs. Low)
3.28 0.014 2.86 0.094
Pulmonary Function Test
FVC percent predicted (Low vs. High) 2.80 0.016 3.14 0.063
DLCO percent predicted (Low vs. High) 3.78 0.012 3.38 0.100
Abbreviations: diffusing capacity of carbon monoxide (DLCO), forced vital capacity (FVC). aIn the subgroup who did not undergo transplantation
Fig. 5 Kaplan Meier survival curves for transplant free survival for the visual fibrosis score (a), the objective interstitial score (b), and the
percentage of interstitial disease that was honeycombing (c)
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scoring systems and the visual presence of a UIP
pattern have been associated with a higher risk of
death [6, 24, 28–33]. While useful, these approaches
are limited by the need trained experts, the time con-
suming process of visual review, and the subjectivity
of visual analysis. For instance, Walsh et al showed
that inter-observer agreement for the presence of UIP
on CT was only 0.40, even for experienced thoracic
radiologists [34]. These limitations suggest a role for
quantitative CT analysis, especially when considering
the analysis of images from larger cohorts.
In prior studies of CT scans obtained as part of
research protocols, higher values of MLD and lower
values of skewness and kurtosis, have been associated
with worse pulmonary function, with the absolute
value of correlation coefficients ranging from 0.18 to
0.74 [10, 17, 35]. In addition, Best et al found that
skewness and kurtosis were associated with mortality
[6]. In our study, we replicated those results using
non-volumetric, clinically acquired CT scans, suggest-
ing that these methods may be applicable outside of a
research setting. In fact, the levels of association with
FVC and DLCO in particular were higher than previ-
ously described, perhaps due to the relative severity
and homogeneity of disease in our cohort. In addition, we
found that impairments in all of the densitometric mea-
sures that we evaluated were associated with shorter
transplant free survival.
We also evaluated a local histogram and distance
based approach for quantifying radiographic subtypes of
lung tissue. We, and others, have used similar ap-
proaches in the study of emphysema, but there has been
limited evaluation of such methods in IPF, and, to our
knowledge, we are the first to apply this specific tech-
nique, which includes the distance from the pleural sur-
face as part of the analysis, to IPF. [9, 18, 19, 36] We
found that higher values of both the total percentage of
lung occupied by interstitial features and the proportion
of those features that were honeycombing, were strongly
correlated with impairments in FVC% and DLCO%. We
also found that there was a trend toward worse trans-
plant free survival for those with higher total amounts of
interstitial changes, a finding analogous to that of visual
fibrosis scores. In addition, there was worse transplant
free survival for those with a higher proportion of inter-
stitial disease that was honeycombing, a finding which
could be considered analogous to the visual presence of
a UIP type radiographic pattern. For simplicity, we did
not directly evaluate clinical associations with the per-
centage of total lung occupied by honeycombing, how-
ever we did find that the total percentage of lung
occupied by interstitial changes was highly correlated
with the percentage of those changes that were honey-
combing (r = 0.95, p < 0.001) suggesting that the two
may have similar clinical associations.
Prior work by Ley et al showed that a visual fibrosis
score could substitute for DLCO, thus we sought to both
replicate this finding and determine if quantitative mea-
sures could be used in place of this qualitative measure-
ment [16]. We found that both the standard continuous
GAP score and the visual GAP-CT score performed
similarly to their previous descriptions, and that, when
used in place of the visual score, the quantitative mea-
sures based on local histogram analysis (GAP-QCT and
GAP-honeycombing) provided similar results with re-
gard to transplant free survival. The GAP score based on
the densitometric measure HAA% (GAP-HAA) per-
formed nearly, but not quite, as well as the other quanti-
tative CT measures. Together, these findings suggest
that quantitative CT measures could be used in place of
qualitative measures for predicting risk in patients with
IPF, though this interpretation is limited by the explora-
tory nature of this study and the use of only the deriv-
ation cohort for these analyses. Additional studies in
validation cohorts, including those with less severe dis-
ease, will be needed to validate this finding. Of note, for
the GAP-QCT score we utilized a measure of all intersti-
tial changes, including ground glass, while the visual fi-
brosis score only reflects reticular and honeycombing
changes. The latter we chose based on its prior descrip-
tion in the literature [16]. With regard to the former, we
felt that for simplicity it would be best to quantitatively
characterize lung tissue as normal, emphysematous or
interstitial, with the only subgroup analysis being the
analysis of honeycombing due to its known visual associ-
ation with poor outcomes [32]. In this cohort this differ-
ence in fibrosis/interstitial score definition is unlikely to
have dramatically affected the results as the vast majority
(84.1%) of the objective interstitial changes were either
reticular or honeycombing, but additional work will be
needed in larger and less diseased cohorts to determine
what potential role each of the interstitial tissue subtypes
play in the objective CT analysis of IPF.
The strengths of our study include the robustness of
our findings despite the use of clinically acquired data
including not excluding patients with suboptimal




Diffusing Capacity, DLCO 0.66 0.56, 0.75
High Attenuation Area, HAA% 0.59 0.50, 0.68
Visual Fibrosis Score, fibrosis% 0.69 0.61, 0.77
Quantitative Interstitial Score, interstitial% 0.65 0.54, 0.75
Percentage of Interstitial Disease Occupied
by Honeycombing, Honeycombing%
0.62 0.52, 0.71
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imaging. In addition, using the local histogram and dis-
tance based approach we were able to specifically evalu-
ate the association of a particular radiographic tissue
type with more severe disease. This method, while in
many ways more complex than densitometry, provides a
more intuitive result: the percentage of lung occupied by
interstitial disease. This simplicity may make this
method more clinically usable than other, less intuitive
measures. The local histogram based approach may also
be more accurate than densitometry in subjects who
have both emphysema and IPF as low attenuation em-
physematous areas may confound whole lung densito-
metric measures. Future studies will be needed to
evaluate this possibility, as well as to compare the per-
formance of this method against other densitometric,
local histogram, and textural analysis based approaches
[6–13, 16, 17, 37]. Finally, while the local histogram and
distance based approach is a somewhat complex method
to initially deploy, if validated, then it could be easily
scaled to analyze as many CT scans as desired, without
the need for time consuming visual reads by a single
expert, and with the reproducibility that may be lacking
if visual analysis is performed by multiple experts. This
scalability would allow its use in potentially much larger
research and clinical cohorts.
This study does have several weaknesses, including the
small sample size, the single center retrospective design,
the use of a cohort with biopsy proven and very severe
disease, the inclusion of training cases in the final ana-
lysis, and the need to augment the automated lung
segmentation with manual editing in the majority of the
cases. Of particular note are the sample size, which
limited our ability to adjust for other covariates in
the mortality models, and the disease severity based
both on the percentages of interstitial disease and the
high rates of death and transplant, which potentially
limit generalizability to those patients with less severe
disease. The latter limitation is likely due in part to
the fact that as a tertiary referral and transplant cen-
ter, many of the patients we see have more advanced
disease, as well as because of our choice to only in-
clude those patients with biopsy proven IPF. We
chose to include only those with biopsy proven IPF
to ensure that our findings were related to that dis-
ease in particular, however, it should be noted that
during the visual review process it was noted that the
vast majority of subjects did have visual CT findings
highly consistent with IPF, suggesting that based on
current guidelines a significant number of the biop-
sies may not have been performed. Finally, while the
relatively high percentages of objectively defined inter-
stitial changes and honeycombing seen in our study
are to some extent likely due to the disease severity
in the cohort, and while the visual fibrosis score and
objective interstitial score were highly correlated, the
large absolute difference between the objective and
visual measures suggests that there is likely some over
classification of normal tissue as diseased. This may
be due to the significant radiographic noise present in
the clinically acquired CT scans used for this study,
and additional work is needed using both established
and novel de-noising techniques to account for this
issue [38].
In addition to the aforementioned need for replication
in larger and less diseased cohorts, other areas of future
research include investigating if longitudinal changes in
CT measurements correlate with clinical and physiologic
decline, and, if so, if they are affected in a measurable
way by the new therapeutic agents for IPF. If this were
the case, then these measurements may serve as valuable
surrogate endpoints in clinical trials.
Conclusions
This study of clinically acquired data in patients with bi-
opsy proven IPF demonstrated that both densitometric
and feature based quantitative CT measurements were
associated in FVC% and DLCO%, as well as with trans-
plant free survival. In addition, GAP scores that incorp-
orate quantitative CT measures in place of either DLCO
or visual CT measures are associated with transplant
free survival. Further work is needed to replicate these
associations in larger and less severely diseased cohorts
and to determine if changes in CT measurements over
time correlate with other markers of disease severity or
with outcomes such as respiratory exacerbations and
death.
Endnote
1Note that paraseptal emphysema was specifically not
included because of prior experience which revealed its
frequent misclassification as normal tissue, and that no
panlobular emphysema was identified during the train-
ing process.
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Additional file 1: Technical Supplement. (ZIP 73 kb)
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CT: Computed tomography; DLCO%: Percent predicted diffusing capacity for
carbon monoxide; FVC%: Percent predicted forced vital capacity; GAP
score: Gender age and physiology score utilizing diffusing capacity for
carbon monoxide; GAP-CT score: Gender age and physiology score utilizing
the percentage of lung occupied by visually identified fibrotic features in
place of the diffusing capacity for carbon monoxide; GAP-HAA score: Gender
age and physiology score utilizing the percentage of lung occupied by high
attenuation area in place of the diffusing capacity for carbon monoxide;
GAP-honeycombing score: Gender age and physiology score utilizing the
percentage of interstitial features made up of the honeycombing subtype in
place of the diffusing capacity for carbon monoxide; GAP-QCT score: Gender
age and physiology score utilizing the percentage of lung occupied by
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objectively identified interstitial radiographic features in place of the
diffusing capacity for carbon monoxide; HAA%: Percent high attenuating
area; Honeycombing%: Percentage of objectively identified interstitial
radiographic features made up by the honeycombing subtype; ILD: Interstitial
lung disease; IPF: Idiopathic pulmonary fibrosis; LH: Local histogram;
MLD: Mean lung density; Objective interstitial score interstitial%: Percentage
of lung occupied by objectively identified interstitial radiographic features;
PFT: Pulmonary function test; UIP: Usual interstitial pneumonia; Visual fibrosis
score: fibrosis%, Percentage of lung occupied by visually identified interstitial
features
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